Prescription Opioid Abuse
The misuse and abuse of immediate-release opioid pain relievers—such as hydrocodone (Vicodin® and Lortab®) and oxycodone (OxyContin® and Percocet®)—has reached epidemic proportions. As prescribers of these short-acting pain medications, dentists are well positioned to help keep these drugs from becoming a source of harm.
Register for the free webinars on safe opioid prescribing
Calls to Action
Campaigns and Initiatives
The ADA participates in a number of campaigns and initiatives to raise professional awareness about the prevalence of opioid abuse, and encourage dentists to review the latest techniques for managing dental pain in the context of modern-day drug-seeking behavior.
Letters and Testimony reflect the Association's position(s) on specific bills, regulations, and other policy issues, and are based on the major policies and positions (PDF) (Members Only) adopted by the ADA House of Delegates.
- July 14, 2016—Coalition letter (PDF) commending Congress for passing the Comprehensive Addiction and Recovery Act (CARA), and urging that the activities authorized eventually be funded.
- May 10, 2016—Letter (PDF) reiterating the Association's support for the Substance Abuse and Mental Health Administration's (SAMHSA) National Recovery Month.
- April 28, 2016—Letter (PDF) reiterating the Association's support for the Drug Enforcement Administration's (DEA) National Prescription Drug Take-Back Initiative.
- February 24, 2016—Letter (PDF) urging Senate leadership to bring several provisions in S. 524, the Comprehensive Addiction and Recovery Act of 2015, to the floor for a vote by the full Senate.
- February 24, 2016—Letters urging the House Committees on Education and Workforce (PDF), Energy and Commerce (PDF), and the Judiciary (PDF) to issue favorable reports on several provisions in H.R. 953, the Comprehensive Addiction and Recovery Act of 2015, so they may be considered for a vote by the full House of Representatives.
- October 21, 2015—Letter (PDF) outlining the Association's commitment to a partnership to the White House to prevent the widespread abuse of opioid pain medications.
1111 14th Street NW, Suite 1100
Washington, DC 20005
211 East Chicago Avenue
Chicago, IL 60611